articleTop 10% cited
POLYOMAVIRUS DISEASE UNDER NEW IMMUNOSUPPRESSIVE DRUGS
Transplantation · 1999 · Vol. 67(6) · pp. 918–922
Isabelle Binet✉Volker Nickeleit(Taipei Institute of Pathology)Hans H. HirschOlivier D. Prince(Taipei Institute of Pathology)Peter Dalquen(Taipei Institute of Pathology)F Gudat(Taipei Institute of Pathology)Michael J. Mihatsch(Taipei Institute of Pathology)G Thiel
Abstract
Recurrent rejection episodes and high dose immunosuppressive therapy, including tacrolimus, are risk factors for manifest PV kidney graft infection, which has an ominous prognosis.
Polyomavirus and related diseasesTacrolimusMedicineComplicationKidneyImmunosuppressionSurgeryBK virusKidney transplantationTransplantationInternal medicine
MeSH terms
Graft RejectionHumansImmunosuppressive AgentsPolyomavirusRisk FactorsTumor Virus InfectionsKidney TransplantationPolyomavirus Infections
Citations
446
FWCI
7.13
field-weighted impact
References
11
Percentile
98%
vs. same field & year
Citations per year
Cited by
Polyomavirus-Associated Nephropathy in Renal Transplantation: Interdisciplinary Analyses and Recommendations
Transplantation · 2005 · 966 citations
Histological Patterns of Polyomavirus Nephropathy: Correlation with Graft Outcome and Viral Load
American Journal of Transplantation · 2004 · 403 citations
BK-virus nephropathy in renal transplants—tubular necrosis, MHC-class II expression and rejection in a puzzling game
Nephrology Dialysis Transplantation · 2000 · 336 citations
BK Polyomavirus in Solid Organ Transplantation
American Journal of Transplantation · 2013 · 522 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.